Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Pharmacokinetics and Codeine Interaction Study
NCT03335423Phase 1Completed
- Sponsor
- University of Southern Denmark
- Start
- Mar 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by University of Southern Denmark. Primary endpoint: Metformin Area Under Plasma Concentration Curve at 24 hours. Started Mar 2018; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03335423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335423.